Join
Live feed
·
INSIDERFilingvia Quantisnow
Allarity Therapeutics Inc. logo

CEO Jensen Thomas was granted 200,000 shares, increasing direct ownership by 50% to 596,734 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ALLR· Allarity Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALLR (Allarity Therapeutics Inc.) and more on Quantisnow.